PlainPharmaWatch

CMS Open Payments · Program Year 2024

Heron Therapeutics, Inc.

Heron Therapeutics, Inc. reported $944,966.69 across General Payments, Research, and Ownership to 4,695 physicians and teaching hospitals across 4,699 transactions.

$945.0K
All-tracks total
4,699
Transactions
4,695
Recipients
−$18.0K
General Payments vs PY2023

Heron Therapeutics, Inc. reported $944,966.69 across all CMS Open Payments tracks (General + Research + Ownership) to 4,695 physicians and teaching hospitals in Program Year 2024 - ranking #629 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $907,021.69, averaging $201.27 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

CMS Sunshine Act warrant

Manufacturer heron-therapeutics-inc Heron Therapeutics, Inc.

$945.0K · #629/1,925 · 0.0% industry · PY2024

  • TOT $945.0K
  • RANK #629
  • SHARE 0.0%
  • TXN 4,699
  • RCP 4,695
  • CAT 4
  • GEN $907.0K
  • ΔGEN −$18.0K
  • TOP1 15.8%
  • PY 2024

Nearest volume peer: OrganOx Ltd ($944.6K)

Almirall LLC$946.1KHeron Therapeutics, Inc. (th…$945.0KOrganOx Ltd$944.6KVascular Technology, Inc.$943.2KLeica Microsystems Inc.$942.6K
All-tracks payment totals near Heron Therapeutics, Inc. (CMS Open Payments PY2024)

Heron Therapeutics, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

Heron Therapeutics, Inc.'s CMS-reported General Payments decreased by $18.0K (−1.9%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: HERON THERAPEUTICS, INC.PY2023: HERON THERAPEUTICS, INC.PY2024: Heron Therapeutics, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$925.0KPY2024$907.0K
PY2023
$924,993.33
PY2024
$907,021.69

What the Data Shows for Heron Therapeutics, Inc.

Averaging $201.10 per transaction and $201.27 per recipient, Heron Therapeutics, Inc.'s Program Year 2024 total comes to $944,966.69 across 4,699 transactions and 4,695 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #629 of 1,925 companies, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

271 transactions worth $504.3K make "Compensation for Services Other Than Consulting" the top general-payment category in the 4-category breakdown below, 55.6% of General Payments (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Across 4 types of general payments, Heron Therapeutics, Inc.'s largest category was "Compensation for Services Other Than Consulting" at $504.3K - 55.6% of General Payments.

Heron Therapeutics, Inc. reports 4 general-payment categories - the top three are Compensation for Services Other Than Consulting (55.6%), Food and Beverage (22.5%), and Travel and Lodging (12.2%). The remaining 1 category make up 9.7% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.

How Heron Therapeutics, Inc. divides its payments

Ranked by total dollars reported per category

1. Compensation for Services…$504.3K2. Food and Beverage$204.5K3. Travel and Lodging$110.6K4. Consulting Fee$87.6K
Payment Type Amount Transactions
Compensation for Services Other Than Consulting $504.3K 271
Food and Beverage $204.5K 4,107
Travel and Lodging $110.6K 238
Consulting Fee $87.6K 79

Recipient Concentration in General Payments

The five largest recipient relationships account for $349,096.81 (38.5%) of $907,021.69 in this company's General Payments records across 3,532 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Heron Therapeutics, Inc.

The five named recipients with the highest reported General Payments from this company

Randy Robbins$143.3KAlan Rechter$121.9KRussell Tigges$31.1KAlexander Sah$29.1KAndrew Noble$23.6K
  1. 1

    Randy Robbins

    $143,314.71 across 151 reported transactions

  2. 2

    Alan Rechter

    $121,938.09 across 117 reported transactions

  3. 3

    Russell Tigges

    $31,136.35 across 28 reported transactions

  4. 4

    Alexander Sah

    $29,126.55 across 23 reported transactions

  5. 5

    Andrew Noble

    $23,581.11 across 38 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Heron Therapeutics, Inc.'s, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Heron Therapeutics, Inc..

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Heron Therapeutics, Inc..

Showing 6 of 1,924 companies with CMS-reported payment data.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

View saved (companies)
Download Heron Therapeutics, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.